Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MEIP will decline by -40.90% over the next 2 Weeks and hit $1.81 by Thursday, October 2, 2025. In that time frame, MEIP's share price is expected to range between $1.33 and $2.27.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 2, 2025 | 1.36 | 1.81 | 2.30 |
| Oct 1, 2025 | 1.44 | 1.89 | 2.39 |
| Sep 30, 2025 | 1.45 | 1.92 | 2.37 |
| Sep 29, 2025 | 1.54 | 2.00 | 2.48 |
| Sep 26, 2025 | 1.93 | 2.37 | 2.85 |
| Sep 25, 2025 | 1.89 | 2.36 | 2.83 |
| Sep 24, 2025 | 2.00 | 2.44 | 2.92 |
| Sep 23, 2025 | 2.05 | 2.46 | 2.95 |
| Sep 22, 2025 | 2.05 | 2.55 | 3.02 |
| Sep 19, 2025 | 2.46 | 2.91 | 3.39 |
MEIP shares rose +10.43% in Wednesday, September 10, 2025's trading session, rising from a previous close of $2.78 to move at $3.07. The stock demonstrated notable intraday movement (see MEIP's key stats for a full breakdown), fluctuating between $2.85 and $3.25, a +14.04% trading range. While recent weeks have seen some volatility, MEIP has managed to secure a -36.70% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.11M shares changing hands, 97.5K fewer than the previous session. This amounted to $3.41M in total market activity.
Will MEIP Continue Its Downward Trend?
According to analyst ratings and projections for MEIP, MEI Pharma, Inc. shares are anticipated to decrease by -33.47%, potentially reaching $2.30 per share by October 2, 2025. Short-term technical indicators for MEIP currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the MEIP stock forecast, now is not the best time to buy MEIP stock because its current trading price is +69.19% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MEIP covering social and institutional perspectives.
MEIP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MEIP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.73% to 39.12%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 44.94%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.56%, maintains a neutral outlook for the long term. Insights into MEIP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
MEI Pharma, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, MEI Pharma, Inc. (MEIP) is positioned to show a strong performance in October 2025. The price is predicted to move between $15.98 and $16.82, settling at an average of $16.35. This could translate to a +432.57% gain.
November 2025
Based on current market signals, MEI Pharma, Inc. is projected to trend november 2025. We forecast a trading range from $15.94 to $17.04, with a likely average price of $16.50. Investors could expect a potential return of +437.46%.
December 2025
Our predictive algorithms indicate MEI Pharma, Inc. stock may see a shift in December 2025. The expected range spans $14.81–$19.74, with an average target of $16.83. This represents a positive outlook and a possible gain of +448.21%.
January 2026
Analyzing established trends, MEI Pharma, Inc. looks set to move in January 2026. Projections place the stock between $17.15 and $20.63, averaging around $19.39. This suggests a +531.60% gain from current levels.
February 2026
Market indicators suggest MEI Pharma, Inc. could experience notable changes during February 2026. Prices could fluctuate within $12.00 to $17.16, with a midpoint forecast of $13.95. The stock might deliver a +354.40% gain.
March 2026
Forecasting for March 2026, models estimate that MEI Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.94 and $20.11, averaging $16.80. This signals a positive trajectory with potential returns around +447.23%.
April 2026
According to our latest forecast models, MEI Pharma, Inc. (MEIP) is positioned to show a strong performance in April 2026. The price is predicted to move between $12.50 and $19.19, settling at an average of $14.73. This could translate to a +379.80% gain.
May 2026
Based on current market signals, MEI Pharma, Inc. is projected to trend may 2026. We forecast a trading range from $14.02 to $24.36, with a likely average price of $18.89. Investors could expect a potential return of +515.31%.
June 2026
Our predictive algorithms indicate MEI Pharma, Inc. stock may see a shift in June 2026. The expected range spans $14.40–$24.06, with an average target of $18.85. This represents a positive outlook and a possible gain of +514.01%.
July 2026
Analyzing established trends, MEI Pharma, Inc. looks set to move in July 2026. Projections place the stock between $14.00 and $27.05, averaging around $18.34. This suggests a +497.39% gain from current levels.
August 2026
Market indicators suggest MEI Pharma, Inc. could experience notable changes during August 2026. Prices could fluctuate within $21.96 to $34.27, with a midpoint forecast of $27.62. The stock might deliver a +799.67% gain.
September 2026
Forecasting for September 2026, models estimate that MEI Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.65 and $30.22, averaging $23.87. This signals a positive trajectory with potential returns around +677.52%.
MEIP's history of dividends and stock splits also plays a role in long-term investor confidence.

